These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 24750060)

  • 1. Gene patents, patenting life and the impact of court rulings on US stem cell patents and research.
    Matthews KR; Cuchiara ML
    Regen Med; 2014 Mar; 9(2):191-200. PubMed ID: 24750060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The History of Patenting Genetic Material.
    Sherkow JS; Greely HT
    Annu Rev Genet; 2015; 49():161-82. PubMed ID: 26442843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do recent US Supreme Court rulings on patenting of genes and genetic diagnostics affect the practice of genetic screening and diagnosis in prenatal and reproductive care?
    Chandrasekharan S; McGuire AL; Van den Veyver IB
    Prenat Diagn; 2014 Oct; 34(10):921-6. PubMed ID: 24989832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patenting genes: what does Association for Molecular Pathology v. Myriad Genetics mean for genetic testing and research?
    Cartwright-Smith L
    Public Health Rep; 2014 May; 129(3):289-92. PubMed ID: 24790252
    [No Abstract]   [Full Text] [Related]  

  • 5. Intellectual property. Historic patent on embryonic stem cells faces scrutiny.
    Marshall E
    Science; 2014 Jan; 343(6169):359. PubMed ID: 24458618
    [No Abstract]   [Full Text] [Related]  

  • 6. US Supreme Court hears arguments in case of BRCA1 and BRCA2 [corrected] patents.
    McCarthy M
    BMJ; 2013 Apr; 346():f2446. PubMed ID: 23596230
    [No Abstract]   [Full Text] [Related]  

  • 7. Invalidating human gene patenting: the U.S. Supreme Court rules in Association for Molecular Pathology v. Myriad Genetics.
    Kalyvas J; Little AS
    World Neurosurg; 2013 Dec; 80(6):680-1. PubMed ID: 24134909
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.
    Offit K; Bradbury A; Storm C; Merz JF; Noonan KE; Spence R
    J Clin Oncol; 2013 Jul; 31(21):2743-8. PubMed ID: 23766521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.
    Bergin C
    Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Human genes patents: yes or no? Reflections on the ruling of the Supreme Court of the United States].
    Lacadena JR
    Rev Derecho Genoma Hum; 2013; (38):167-81. PubMed ID: 24340831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. US Supreme Court is asked to rule on validity of patents on BRCA1 and BRCA2 genes.
    Dyer C
    BMJ; 2012 Oct; 345():e6624. PubMed ID: 23033368
    [No Abstract]   [Full Text] [Related]  

  • 12. The unpatentable human being.
    Torrance AW
    Hastings Cent Rep; 2013; 43(5):10-1. PubMed ID: 24092583
    [No Abstract]   [Full Text] [Related]  

  • 13. Whose body is it anyway? Human cells and the strange effects of property and intellectual property law.
    Feldman R
    Stanford Law Rev; 2011 Jun; 63(6):1377-402. PubMed ID: 21774193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intellectual property. Supreme Court rules out patents on 'natural' genes.
    Marshall E
    Science; 2013 Jun; 340(6139):1387-8. PubMed ID: 23788772
    [No Abstract]   [Full Text] [Related]  

  • 15. US Supreme Court rules on landmark gene patent case.
    Sklan A
    Pharm Pat Anal; 2013 Sep; 2(5):581. PubMed ID: 24237164
    [No Abstract]   [Full Text] [Related]  

  • 16. Supreme Court will rule on whether patents for BRAC1 and BRAC2 genes are valid.
    Dyer C
    BMJ; 2012 Dec; 345():e8266. PubMed ID: 23223689
    [No Abstract]   [Full Text] [Related]  

  • 17. The end of DNA patents in the United States?
    Webber P
    Expert Opin Ther Pat; 2013 Dec; 23(12):1525-7. PubMed ID: 24138004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for stem cell patent applications in the light of recent court cases.
    Eyre DE; Schlich GW
    Pharm Pat Anal; 2015; 4(6):431-41. PubMed ID: 26580992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intellectual property. In a flurry of metaphors, justices debate a limit on gene patents.
    Marshall E
    Science; 2013 Apr; 340(6131):421. PubMed ID: 23620028
    [No Abstract]   [Full Text] [Related]  

  • 20. Defining "research" in the US and EU: contrast of Sherley v. Sebelius and Brüstle v. Greenpeace rulings.
    Cuchiara ML; Lawford Davies J; Matthews KR
    Stem Cell Rev Rep; 2013 Dec; 9(6):743-51. PubMed ID: 23912336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.